Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Johnson & Johnson MedTech Receives FDA Approval for the VARIPULSE™ Pulsed Field Ablation Platform for the Treatment of Atrial Fibrillation
11/07/2024
Johnson & Johnson Press Release Irvine, CA – November 7, 2024 – Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the...
Johnson & Johnson Press Release Irvine, CA – November 7, 2024 – Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the...
Johnson & Johnson Press...
11/07/2024
EP Lab Digest
News
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
11/04/2024
Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company.
Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Cortex, Inc., an Ajax Health company.
Boston Scientific Corporation...
11/04/2024
EP Lab Digest

Advertisement

News
The One-Year Outcome of LuX-Valve Plus TRAVEL II Study was Officially Released at TCT 2024
10/31/2024
Jenscare Scientific Co., Ltd., releases the 1-year outcome of LuX-Valve Plus TRAVEL II study at the 2024 Transcatheter Cardiovascular Therapeutics Conference (TCT 2024).
Jenscare Scientific Co., Ltd., releases the 1-year outcome of LuX-Valve Plus TRAVEL II study at the 2024 Transcatheter Cardiovascular Therapeutics Conference (TCT 2024).
Jenscare Scientific Co.,...
10/31/2024
EP Lab Digest
News
Tempus and Northwestern Medicine Announce Collaboration to Bring Practical Application of AI to Healthcare
10/31/2024
Tempus, a leader in artificial intelligence and precision medicine, and Northwestern Medicine, Chicago’s premier integrated academic health system, today announced a collaboration that aims to explore the application of artificial...
Tempus, a leader in artificial intelligence and precision medicine, and Northwestern Medicine, Chicago’s premier integrated academic health system, today announced a collaboration that aims to explore the application of artificial...
Tempus, a leader in artificial...
10/31/2024
EP Lab Digest
News
MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System
10/29/2024
MedLumics, a medical device company developing fiber optically guided platform technologies for the treatment, initially, of Atrial fibrillation (AF), announced today 10 patients treated in the company’s First in Man clinical trial.
MedLumics, a medical device company developing fiber optically guided platform technologies for the treatment, initially, of Atrial fibrillation (AF), announced today 10 patients treated in the company’s First in Man clinical trial.
MedLumics, a medical device...
10/29/2024
EP Lab Digest

Advertisement

News
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
10/29/2024
iRhythm Technologies, Inc., announces that the results of the Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk Ventricular Tachyarrhythmias in Patients with Hypertrophic Cardiomyopathy (EXAMINE-HCM) study have been...
iRhythm Technologies, Inc., announces that the results of the Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk Ventricular Tachyarrhythmias in Patients with Hypertrophic Cardiomyopathy (EXAMINE-HCM) study have been...
iRhythm Technologies, Inc.,...
10/29/2024
EP Lab Digest
Orsif
meeting update
Inaugural Global Symposium on Interventional Radiation Protection to Focus on Keeping Lab-Based Clinicians Safe
10/28/2024
HMP Global, in partnership with Occupational Radiation Safety in Interventional Fluoroscopy (ORSIF), will host the first-of-its-kind Global Symposium on Interventional Radiation Protection (SIRP), to be held September 26-27, 2025.
HMP Global, in partnership with Occupational Radiation Safety in Interventional Fluoroscopy (ORSIF), will host the first-of-its-kind Global Symposium on Interventional Radiation Protection (SIRP), to be held September 26-27, 2025.
HMP Global, in partnership with...
10/28/2024
EP Lab Digest
The pivotal investigational device exemption (IDE) study, which enrolled 256 patients at 18 sites in the US, met the primary endpoint. MACCE (Major Adverse Cardiac and Cerebrovascular Events) rate at 30 days was 6.3%, significantly below the pre-defined performance goal (see figure 1).
Mechanical Circulatory Support
TCT: Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI
10/28/2024
The pivotal investigational device exemption (IDE) study, which enrolled 256 patients at 18 sites in the US, met the primary endpoint. MACCE (Major Adverse Cardiac and Cerebrovascular Events) rate at 30 days was 6.3%, significantly below the...
The pivotal investigational device exemption (IDE) study, which enrolled 256 patients at 18 sites in the US, met the primary endpoint. MACCE (Major Adverse Cardiac and Cerebrovascular Events) rate at 30 days was 6.3%, significantly below the...
The pivotal investigational...
10/28/2024
Cath Lab Digest

Advertisement

News
A New Paradigm in Electrophysiology: Medtronic Receives FDA Approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter
10/25/2024
Medtronic Press Release  GALWAY, Ireland, Oct. 24, 2024 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the...
Medtronic Press Release  GALWAY, Ireland, Oct. 24, 2024 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the...
Medtronic Press...
10/25/2024
EP Lab Digest
News
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
10/24/2024
Adagio Medical Holdings, Inc., announces the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration (FDA) Pivotal IDE study of Adagio’s VT Cryoablation System.
Adagio Medical Holdings, Inc., announces the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration (FDA) Pivotal IDE study of Adagio’s VT Cryoablation System.
Adagio Medical Holdings, Inc.,...
10/24/2024
EP Lab Digest

Advertisement

EPLD November 2024 cover

Current Issue

November 2024
Volume 24
Issue 11
Current Issue
Issue Archive

Advertisement

Advertisement

Stay in the know.

EP Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use